IL271395A - Treatment of sexual dysfunction and improvement in sexual quality of life - Google Patents
Treatment of sexual dysfunction and improvement in sexual quality of lifeInfo
- Publication number
- IL271395A IL271395A IL271395A IL27139519A IL271395A IL 271395 A IL271395 A IL 271395A IL 271395 A IL271395 A IL 271395A IL 27139519 A IL27139519 A IL 27139519A IL 271395 A IL271395 A IL 271395A
- Authority
- IL
- Israel
- Prior art keywords
- sexual
- improvement
- quality
- treatment
- life
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762521765P | 2017-06-19 | 2017-06-19 | |
| PCT/US2018/037725 WO2018236680A1 (en) | 2017-06-19 | 2018-06-15 | TREATMENT OF SEXUAL DYSFUNCTION AND IMPROVEMENT OF THE QUALITY OF SEXUAL LIFE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL271395A true IL271395A (en) | 2020-01-30 |
Family
ID=62952383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL271395A IL271395A (en) | 2017-06-19 | 2019-12-12 | Treatment of sexual dysfunction and improvement in sexual quality of life |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12496316B2 (enExample) |
| EP (1) | EP3641793A1 (enExample) |
| JP (1) | JP7343123B2 (enExample) |
| KR (1) | KR20200017516A (enExample) |
| CN (1) | CN111107858A (enExample) |
| AU (1) | AU2018288653A1 (enExample) |
| CA (1) | CA3067354A1 (enExample) |
| IL (1) | IL271395A (enExample) |
| SG (1) | SG11201912209UA (enExample) |
| TW (1) | TW201919664A (enExample) |
| WO (1) | WO2018236680A1 (enExample) |
| ZA (1) | ZA201908451B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021340971A1 (en) | 2020-09-08 | 2023-03-30 | Longeveron, Inc. | Treatment of Alzheimer's disease with allogeneic mesenchymal stem cells |
| EP4376950A1 (en) | 2021-07-26 | 2024-06-05 | Longeveron Inc. | Use of mesenchymal stem cells in treatment of juvenile hypoplastic left heart syndrome |
| CA3226181A1 (en) | 2021-09-10 | 2023-03-16 | Longeveron Inc. | Treatment of aging frailty comprising administering bone marriw derived mesenchymal stem cells |
| KR102762783B1 (ko) * | 2022-01-21 | 2025-02-05 | 고현서 | 심리 프로파일에 따른 행동 습관 제공 방법, 서버, 저장 매체 및 디바이스 |
| WO2025137077A1 (en) | 2023-12-19 | 2025-06-26 | Longeveron, Inc. | Improved brain architecture and biomarkers in alzheimer's disease with mesenchymal stem cells |
| WO2025199451A2 (en) | 2024-03-21 | 2025-09-25 | Longeveron Inc. | Mmp-14 potency assay for mesenchymal stem cells |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL120266A (en) | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
| WO2007149548A2 (en) * | 2006-06-22 | 2007-12-27 | Medistem Laboratories, Inc. | Treatment of erectile dysfunction by stem cell therapy |
| WO2010021996A1 (en) * | 2008-08-18 | 2010-02-25 | Junta De Beneficiencia De Guayaquil | Treatment of injuries to the central nervous system |
| EP2486930B1 (en) | 2009-10-06 | 2016-03-23 | National University Corporation Nagoya University | Cell preparation containing adipose tissue derived mesenchymal stem cells for use in the treatment of a condition of no urge to urinate |
| WO2013173694A2 (en) * | 2012-05-18 | 2013-11-21 | The Cooper Health System | A method of restoring endothelial/smooth muscle architecture and cell signaling pathways to sexual organs |
| EA202190962A2 (ru) | 2014-05-30 | 2022-02-28 | Оникс Терапьютикс, Инк. | Уровни экспрессии иммуноглобулинов в качестве биологического маркера для реакции на ингибитор протеасом |
| CN105055450A (zh) | 2015-02-13 | 2015-11-18 | 中国福利会国际和平妇幼保健院 | 人宫内膜干细胞在制备治疗卵巢早衰的药物中的应用 |
-
2018
- 2018-06-15 US US16/624,118 patent/US12496316B2/en active Active
- 2018-06-15 CN CN201880046823.4A patent/CN111107858A/zh active Pending
- 2018-06-15 SG SG11201912209UA patent/SG11201912209UA/en unknown
- 2018-06-15 EP EP18742863.6A patent/EP3641793A1/en active Pending
- 2018-06-15 WO PCT/US2018/037725 patent/WO2018236680A1/en not_active Ceased
- 2018-06-15 JP JP2020519007A patent/JP7343123B2/ja active Active
- 2018-06-15 CA CA3067354A patent/CA3067354A1/en active Pending
- 2018-06-15 KR KR1020207001647A patent/KR20200017516A/ko not_active Withdrawn
- 2018-06-15 AU AU2018288653A patent/AU2018288653A1/en not_active Abandoned
- 2018-06-19 TW TW107120931A patent/TW201919664A/zh unknown
-
2019
- 2019-12-12 IL IL271395A patent/IL271395A/en unknown
- 2019-12-18 ZA ZA2019/08451A patent/ZA201908451B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US12496316B2 (en) | 2025-12-16 |
| CN111107858A (zh) | 2020-05-05 |
| SG11201912209UA (en) | 2020-01-30 |
| AU2018288653A1 (en) | 2020-01-16 |
| JP2020524179A (ja) | 2020-08-13 |
| TW201919664A (zh) | 2019-06-01 |
| WO2018236680A1 (en) | 2018-12-27 |
| ZA201908451B (en) | 2021-05-26 |
| EP3641793A1 (en) | 2020-04-29 |
| JP7343123B2 (ja) | 2023-09-12 |
| US20200129558A1 (en) | 2020-04-30 |
| CA3067354A1 (en) | 2018-12-27 |
| KR20200017516A (ko) | 2020-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202006746B (en) | Methods of treatment | |
| IL273693A (en) | Treatment of inflammatory disorders | |
| IL271395A (en) | Treatment of sexual dysfunction and improvement in sexual quality of life | |
| EP3678681A4 (en) | INTERLEUKIN-18 VARIANTS AND THEIR PROCEDURES FOR USE | |
| HUE064141T2 (hu) | Azolopirimidin rákkal összefüggõ rendellenességek kezelésére | |
| IL274865A (en) | Treatment methods with asparaginase | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| IL283782A (en) | Analosomes and methods of use | |
| SG11202004680UA (en) | Cellular compositions and methods of treatment i | |
| EP3307280A4 (en) | TREATMENT OF SEXUAL DYSFUNCTION | |
| DK3273995T3 (da) | Kombineret anvendelse af alginatoligomerer og cftr-modulatoren lumacaftor i behandlingen af tilstande associeret med cftr-dysfunktion | |
| IL270900A (en) | Treatment of cutaneous disorders | |
| IL275349A (en) | Use of hM4Di in the treatment of seizure disorders | |
| ZA201903795B (en) | Treatment of water | |
| DK3270608T3 (da) | Høreindretning med adaptiv behandling og relateret fremgangsmåde | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| IL274838A (en) | Use of MIR101 or MIR128 in the treatment of seizure disorders | |
| HUE062859T2 (hu) | Szennyvíz kezelése | |
| IL270362B (en) | Glaucoma treatment | |
| GB201614415D0 (en) | Enzymes for the treatment of human enterometabolic dysfunction | |
| SG11202005850VA (en) | Methods of treatment of hypertrigl yceridemia | |
| EP3565541A4 (en) | TREATMENT OF SEXUAL DYSFUNCTION | |
| EP3532031A4 (en) | TREATMENT OF SEXUAL DYSFUNCTION | |
| SMT202100037T1 (it) | Trattamento dell'emicrania con acetil-leucina | |
| IL257225A (en) | Treatment of sarcoma |